MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,603,499 | -32.8% | 224,657 | -3.0% | 0.00% | -50.0% |
Q2 2023 | $5,365,891 | -2.6% | 231,488 | -2.4% | 0.00% | 0.0% |
Q1 2023 | $5,508,786 | +56.1% | 237,141 | -2.5% | 0.00% | +100.0% |
Q4 2022 | $3,528,539 | -22.0% | 243,180 | +2.6% | 0.00% | -50.0% |
Q3 2022 | $4,524,000 | +1.1% | 237,074 | -3.8% | 0.00% | 0.0% |
Q2 2022 | $4,476,000 | -26.6% | 246,332 | +1.9% | 0.00% | 0.0% |
Q1 2022 | $6,094,000 | -9.3% | 241,826 | -0.7% | 0.00% | 0.0% |
Q4 2021 | $6,719,000 | -4.5% | 243,469 | +11.7% | 0.00% | 0.0% |
Q3 2021 | $7,038,000 | +10.0% | 217,996 | +4.1% | 0.00% | 0.0% |
Q2 2021 | $6,401,000 | -19.0% | 209,349 | -19.3% | 0.00% | -33.3% |
Q1 2021 | $7,904,000 | +62.0% | 259,555 | +5.2% | 0.00% | +50.0% |
Q4 2020 | $4,879,000 | +52.4% | 246,728 | +0.5% | 0.00% | +100.0% |
Q3 2020 | $3,202,000 | +15.5% | 245,530 | +0.4% | 0.00% | 0.0% |
Q2 2020 | $2,773,000 | -15.5% | 244,534 | +6.7% | 0.00% | -50.0% |
Q1 2020 | $3,281,000 | -47.5% | 229,250 | -0.2% | 0.00% | -33.3% |
Q4 2019 | $6,255,000 | +4.0% | 229,676 | +9.4% | 0.00% | 0.0% |
Q3 2019 | $6,012,000 | +6.7% | 210,005 | +3.5% | 0.00% | 0.0% |
Q2 2019 | $5,634,000 | -13.8% | 202,813 | +3.0% | 0.00% | -25.0% |
Q1 2019 | $6,539,000 | +26.0% | 196,956 | +9.8% | 0.00% | 0.0% |
Q4 2018 | $5,189,000 | -32.1% | 179,343 | +8.1% | 0.00% | -20.0% |
Q3 2018 | $7,646,000 | +37.0% | 165,855 | +10.8% | 0.01% | +25.0% |
Q2 2018 | $5,582,000 | +33.4% | 149,669 | +5.8% | 0.00% | +33.3% |
Q1 2018 | $4,185,000 | -11.2% | 141,462 | +3.0% | 0.00% | 0.0% |
Q4 2017 | $4,715,000 | -3.8% | 137,277 | +1.4% | 0.00% | -25.0% |
Q3 2017 | $4,900,000 | +44.0% | 135,421 | +2.8% | 0.00% | +33.3% |
Q2 2017 | $3,403,000 | +45.7% | 131,723 | +8.2% | 0.00% | +50.0% |
Q1 2017 | $2,336,000 | +454.9% | 121,700 | +382.0% | 0.00% | – |
Q4 2016 | $421,000 | +15.0% | 25,248 | +42.8% | 0.00% | – |
Q3 2016 | $366,000 | -22.6% | 17,686 | +14.5% | 0.00% | – |
Q2 2016 | $473,000 | -18.0% | 15,448 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $577,000 | -5.1% | 15,448 | +10.6% | 0.00% | 0.0% |
Q4 2015 | $608,000 | +25.4% | 13,968 | +7.2% | 0.00% | 0.0% |
Q3 2015 | $485,000 | +10.7% | 13,031 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $438,000 | +484.0% | 13,031 | +518.2% | 0.00% | – |
Q1 2015 | $75,000 | – | 2,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |